An interventional study of Recovering Together in Acute Brain Injuries, sponsored by Massachusetts General Hospital. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-28.
Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Prevention
The investigators will compare a dyadic intervention (Recovering Together) with an attention placebo educational control in dyads of patients with acute neurological illnesses and their caregivers at risk for chronic emotional distress. The primary aim of this study is to determine the feasibility, credibility, and satisfaction with Recovering Together. The second aim is to show proof of concept for sustained improvement in emotional distress, post traumatic stress (PTS), resiliency and interpersonal communication outcomes in patients and caregivers.
The investigators aim to improve the care of patients (pts) admitted to the Neuroscience Intensive Care Unit (NICU) and their family caregivers (cgs) by conducting a pilot feasibility randomized controlled trial (RCT; N=80 dyads; 60 completers) of the dyadic resiliency program ("Recovering Together") to prevent chronic emotional distress in both pts and their cgs. Eligible dyads include adult, English speaking pts with acute neurological injury (ANI) admitted to the NICU, cleared medically and cognitively for participation by the nursing team, and their primary cgs. Dyads who are randomly assigned to "Recovering Together" will receive 6 manualized sessions (2 in person at hospitalization and 4 through live video after discharge, to reduce burden and facilitate access to care) led by a clinical psychologist. Dyads who are randomly assigned to the attention placebo educational control condition will receive 6 manualized sessions (2 in person and 4 through live video with a clinical psychologist), modeled after the Recovering Together program that will control for the dose of the intervention and support from therapist. Dyads will complete assessment surveys before, after the intervention and 3 months later. Clinical data on demographics, diagnosis, ANI severity, and any medical complications will be extracted from electronic health records.
2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.
This study's enrollment of 126 is above the median of 48 across 1,331 interventional studies indexed under Brain Injuries.
Browse Brain Injuries studies →Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.
Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Dyads who are randomly assigned to the Recovering Together program will receive any usual clinic care as determined by their clinicians. Additionally, dyads will be invited to participate in 6 30-minute skills sessions. All sessions will include both pt and cg. A clinical psychologist will deliver the majority of sessions while the PI will deliver at least 10% of the sessions. The main intervention goal is to provide dyads with resiliency and interpersonal communication skills necessary to optimize their recovery and reduce emotional distress and PTS.
Behavioral: Recovering Together
Patients randomly assigned to the control condition will receive an educational program that mimics the dose and duration of the Recovering Together Program but without teaching any of the resiliency or interpersonal communication skills that are hypothesized to be responsible for improvement in emotional distress. The control will entail 2 in-person dyadic visits in the NICU and 4 dyadic virtual visits after discharge.
The intervention will teach resiliency skills (mindfulness, coping, interpersonal communication, etc) within 2 in person sessions at hospitalization and 4 live video sessions after discharge. Both patient and caregiver will participate in all sessions
Feasibility of Recruitment (Ability to Recruit Dyads)
Feasibility of recruitment will be determined by reporting number of dyads who meet study criteria who enrolled
Time frame: Baseline
Feasibility of Intervention Delivery (Ability to Deliver Intervention to Dyads)
We will report number of sessions completed by each dyad. We will report any technical difficulties with live video delivery
Time frame: Feasibility of program delivery will be measured at 6 weeks
Credibility and Expectancy Questionnaire
This measure will assess participants' belief that the intervention (or control) will be helpful. The score range is 3-27. Higher scores mean higher perception of credibility or expectancy.
Time frame: Baseline
Client Satisfaction Questionnaire
This measure will assess participants' satisfaction with participation in the study. The score range is 0-12. Higher scores indicate greater satisfaction.
Time frame: post intervention (6 weeks after baseline)
Hospital Anxiety and Depression Scale
Measures symptoms of emotional distress and estimates diagnoses. The scale has 14 items, 7 assess anxiety and 7 depression. Scores range from 0-21 on each subscale, wtih higher scores indicating more symptoms. Scores greater than 8 indicate clinically significant symptoms.
Time frame: baseline to posttest to 3 months follow up
Post Traumatic Checklist
The PTSD CheckList - Civilian Version measures symptoms of post traumatic stress and determines diagnoses. Scores range from 17-85. Higher scores indicate more severe stress.
Time frame: baseline to posttest to 3 months follow up
Measures of Coping Style Part A
The MOCS-A measures various coping strategies such as relaxation or adaptive thinking. Scores range from 0 to 52, and higher scores indicate greater self-perceived proficiency with these skills.
Time frame: baseline to posttest to 3 months follow up
Cognitive and Affective Mindfulness Scale Revised
Measures mindfulness skills used in daily life. The scale ranges from 12 to 48 with higher scores indicating higher mindfulness.
Time frame: baseline to post test to 3 months follow up
Dyadic Relationship Scale
The Dyadic Relationship Scale (DRS) has 2 sub scales that assess dyadic strains and dyadic positive interaction. Scales on each sub scale range from 1 to 4, with higher scores indicating great severity of the relevant construct.
Time frame: Baseline, post treatment, 3-month follow-up
| Milestone | Recovering Together | Health Education |
|---|---|---|
| Started | 60 | 62 |
| Patient | 30 | 31 |
| Caregiver | 30 | 31 |
| Completed | 56 | 59 |
| Not completed | 4 | 3 |
| Withdrew: Withdrawal by subject | 2 | 0 |
| Withdrew: Lost to follow-up | 2 | 3 |
Feasibility of recruitment will be determined by reporting number of dyads who meet study criteria who enrolled
| Participants | Eligible Participants |
|---|---|
| Participants who enrolled and randomized | 122 |
| Participants who declined | 40 |
| Participants who enrolled and did not randomize | 4 |
We will report number of sessions completed by each dyad. We will report any technical difficulties with live video delivery
| dyads | Recovering Together | Health Education |
|---|---|---|
| Number of dyads who started RT who had at least 1 member complete post treatment assessment | 29 | 31 |
| Number of dyads who started RT who had neither member complete post treatment assessment | 1 | 0 |
This measure will assess participants' belief that the intervention (or control) will be helpful. The score range is 3-27. Higher scores mean higher perception of credibility or expectancy.
| score on a scale | Recovering Together | Health Education |
|---|---|---|
| Credibility and Expectancy Questionnaire; credibility subscale | 22.0 ± 4.4 | 20.3 ± 4.8 |
| Credibility and Expectancy Questionnaire; expectancy subscale | 19.0 ± 5.2 | 19.5 ± 5.6 |
This measure will assess participants' satisfaction with participation in the study. The score range is 0-12. Higher scores indicate greater satisfaction.
| score on a scale | Recovering Together | Health Education |
|---|---|---|
| Client Satisfaction Questionnaire | 10.65 ± 1.18 | 9.87 ± 2.70 |
Measures symptoms of emotional distress and estimates diagnoses. The scale has 14 items, 7 assess anxiety and 7 depression. Scores range from 0-21 on each subscale, wtih higher scores indicating more symptoms. Scores greater than 8 indicate clinically significant symptoms.
| score on a scale | Recovering Together: Patients | Recovering Together: Caregivers | Health Education: Patients | Health Education: Caregivers |
|---|---|---|---|---|
| Baseline: depression | 8.7 ± 4.2 | 7.8 ± 2.7 | 7.1 ± 4.0 | 4.8 ± 3.8 |
| Posttreatment: depression | 4.0 ± 4.1 | 3.28 ± 3.37 | 7.2 ± 3.7 | 6.1 ± 5.4 |
| 3-month follow-up: depression | 3.7 ± 3.3 | 2.42 ± 2.58 | 7.7 ± 5.0 | 7.27 ± 5.28 |
| Baseline: anxiety | 11.1 ± 4.7 | 13.2 ± 3.9 | 6.3 ± 4.0 | 7.0 ± 4.7 |
| Posttreatment: anxiety | 3.3 ± 4.1 | 6.0 ± 3.8 | 8.5 ± 5.2 | 8.1 ± 6.1 |
| 3-month follow-up: anxiety | 4.7 ± 4.8 | 5.3 ± 3.8 | 8.9 ± 6.0 | 9.62 ± 5.02 |
The PTSD CheckList - Civilian Version measures symptoms of post traumatic stress and determines diagnoses. Scores range from 17-85. Higher scores indicate more severe stress.
| score on a scale | Recovering Together: Patients | Recovering Together: Caregivers | Health Education: Patients | Health Education: Caregivers |
|---|---|---|---|---|
| Baseline | 41.6 ± 12.9 | 43.2 ± 10.7 | 29.3 ± 12.1 | 29.4 ± 12.0 |
| Posttreatment | 26.4 ± 10.8 | 39.3 ± 9.8 | 34.6 ± 12.1 | 35.9 ± 16.6 |
| 3-month follow-up | 28.2 ± 10.1 | 27.3 ± 7.7 | 41.7 ± 16.0 | 37.7 ± 16.1 |
The MOCS-A measures various coping strategies such as relaxation or adaptive thinking. Scores range from 0 to 52, and higher scores indicate greater self-perceived proficiency with these skills.
| score on a scale | Recovering Together: Patients | Recovering Together: Caregivers | Health Education: Patients | Health Education: Caregivers |
|---|---|---|---|---|
| Baseline | 2.2 ± .8 | 2.3 ± .6 | 2.6 ± .9 | 2.5 ± .9 |
| Posttest | 2.7 ± .8 | 2.6 ± 1.1 | 2.4 ± .8 | 2.4 ± 1.2 |
| 3-month follow-up | 2.5 ± .7 | 2.5 ± .9 | 2.2 ± 1.0 | 2.3 ± 1.0 |
Measures mindfulness skills used in daily life. The scale ranges from 12 to 48 with higher scores indicating higher mindfulness.
| score on a scale | Recovering Together: Patients | Recovering Together: Caregivers | Health Education: Patients | Health Education: Caregivers |
|---|---|---|---|---|
| Baseline | 34.2 ± 7.0 | 34.6 ± 5.8 | 35.1 ± 7.8 | 36.4 ± 7.6 |
| Posttreatment | 36.7 ± 7.7 | 36.3 ± 6.5 | 35.0 ± 10.7 | 36.7 ± 8.5 |
| 3-month follow-up | 35.5 ± 7.9 | 36.3 ± 7.5 | 32.3 ± 9.0 | 33.3 ± 9.4 |
The Dyadic Relationship Scale (DRS) has 2 sub scales that assess dyadic strains and dyadic positive interaction. Scales on each sub scale range from 1 to 4, with higher scores indicating great severity of the relevant construct.
| score on a scale | Recovering Together: Patients | Recovering Together: Caregivers | Health Education: Patients | Health Education: Caregivers |
|---|---|---|---|---|
| Dyadic strain: baseline | 2.0 ± .8 | 2.0 ± .7 | 2.0 ± .78 | 1.8 ± .7 |
| Dyadic strain: posttreatment | 1.6 ± .6 | 2.01 ± .8 | 2.0 ± .9 | 2.1 ± .9 |
| Dyadic strain: 3-month follow-up | 1.9 ± .8 | 2.2 ± .8 | 2.0 ± .9 | 2.2 ± .8 |
| Positive interactions: baseline | 3.1 ± .5 | 3.0 ± .5 | 3.2 ± .6 | 3.3 ± .4 |
| Positive interactions: posttreatment | 3.4 ± .6 | 3.3 ± .5 | 2.97 ± .77 | 3.2 ± .7 |
| Positive interactions: 3-month follow-up | 3.2 ± .6 | 3.2 ± .6 | 2.82 ± .67 | 3.0 ± .7 |
Collected over 3 months. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Recovering Together: Patients | 0/30 (0%) | 0/30 (0%) | 0/30 (0%) |
| Recovering Together: Caregivers | 0/30 (0%) | 0/30 (0%) | 0/30 (0%) |
| Health Education: Patients | 0/31 (0%) | 0/31 (0%) | 0/31 (0%) |
| Health Education: Caregivers | 0/31 (0%) | 0/31 (0%) | 0/31 (0%) |
Total number of participants (patients and caregivers) who completed \>=1 intervention or control session were analyzed and included in baseline population.
| Age, Continuous(Years) | Recovering Together: Patients | Recovering Together: Caregivers | Health Education: Patients | Health Education: Caregivers | Total |
|---|---|---|---|---|---|
| Mean | 49.3 ± 16.7 | 52.4 ± 14.3 | 50.1 ± 16.4 | 52.1 ± 14.9 | 50.9 ± 15.5 |
| Sex: Female, Male(Participants) | Recovering Together: Patients | Recovering Together: Caregivers | Health Education: Patients | Health Education: Caregivers | Total |
|---|---|---|---|---|---|
| Female | 9 | 22 | 12 | 17 | 60 |
| Male | 20 | 7 | 17 | 12 | 56 |
| Race (NIH/OMB)(Participants) | Recovering Together: Patients | Recovering Together: Caregivers | Health Education: Patients | Health Education: Caregivers | Total |
|---|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 | 0 | 0 |
| Asian | 1 | 0 | 1 | 1 | 3 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
| Black or African American | 2 | 4 | 2 | 3 | 11 |
| White | 25 | 25 | 24 | 20 | 94 |
| More than one race | 1 | 0 | 1 | 1 | 3 |
| Unknown or Not Reported | 0 | 0 | 1 | 4 | 5 |
| Employment status(Participants) | Recovering Together: Patients | Recovering Together: Caregivers | Health Education: Patients | Health Education: Caregivers | Total |
|---|---|---|---|---|---|
| Employed full-time | 18 | 14 | 12 | 18 | 62 |
| Retired | 5 | 6 | 8 | 4 | 23 |
| Employed part-time | 1 | 3 | 1 | 2 | 7 |
| Homemaker | 0 | 2 | 1 | 2 | 5 |
| Full-time or part-time student | 1 | 1 | 1 | 1 | 4 |
| Other | 4 | 3 | 6 | 2 | 15 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Massachusetts General Hospital